Zenith Drugs Ltd Wins Tender Worth ₹6.8 Million to Supply Pregabalin Capsules

Zenith Drugs Ltd has secured a significant tender valued at ₹6.8 million to supply Pregabalin Capsules IP. This win underscores Zenith Drugs' capabilities in the pharmaceutical sector, particularly in the production and supply of high-quality, affordable medications. Pregabalin is a widely used drug for treating epilepsy, neuropathic pain, and other neurological conditions. The tender award reflects Zenith Drugs' competitive pricing and compliance with stringent quality standards, positioning the company as a reliable supplier in the Indian pharmaceutical market. This development is expected to enhance Zenith Drugs' revenue and reinforce its market presence, aligning with the company's strategy to expand its product portfolio and strengthen its position in the domestic and international markets.

Source: Pharmaceutical Industry News